Abstract
In this thesis we aim to optimize existing immunotherapy for hepatocellular carcinoma (HCC) with a strong emphasis on checkpoint inhibition. We aim to detect tumor-associated mutations in paired circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in a western cohort of HCC patients.
| Original language | English |
|---|---|
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 1 Jun 2021 |
| Place of Publication | Rotterdam |
| Print ISBNs | 978-94-6416-629-3 |
| Publication status | Published - 1 Jun 2021 |
Bibliographical note
The research was funded by:- China Scholarship Council
- Nederlandse Vereniging Voor Gastro-enterologie
Fingerprint
Dive into the research topics of 'Hepatocellular Carcinoma: from Liquid Biopsy to Immunotherapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver